Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Gary E. Zurenko"'
Publikováno v:
Clinical Infectious Diseases. 58:S35-S42
The emerging antibiotic resistance of Gram-positive pathogens represents a significant challenge to the management of human infections. The novel oxazolidinone tedizolid demonstrates antimicrobial activity across a broad range of Gram-positive pathog
Publikováno v:
Antimicrobial Agents and Chemotherapy. 53:3236-3239
TR-701 is the prodrug of the microbiologically active molecule TR-700, a novel orally and intravenously administered oxazolidinone antibacterial agent. The in vitro activity of TR-700 was evaluated against 1,063 bacterial clinical isolates including
Autor:
Vickie Brown-Driver, Dean L. Shinabarger, Karen Joy Shaw, Gary E. Zurenko, Chris M. Pillar, John T. Finn, S. Poppe, Ronda D. Schaadt
Publikováno v:
Antimicrobial Agents and Chemotherapy. 52:4442-4447
TR-701 is the orally active prodrug of TR-700, a novel oxazolidinone that demonstrates four- to eightfold-greater activity than linezolid (LZD) against Staphylococcus and Enterococcus spp. In this study evaluating the in vitro sensitivity of LZD-resi
Autor:
Mark C. Sulavik, Ji-Young Kim, Rose Kelly, Allison Laura Choy, Roger J. Brideau, Poel Toni-Jo, Joanne Brodfuehrer, Gary E. Zurenko, Tong Zhu, Michael Dority, Cai Hongliang, Barbachyn Michael R, Joan K. Brieland, Thomas Richard C, Frederick E. Boyer, Michael R. Dermyer, Martin Joseph P, Michael D. Huband, Alan P. Brown, Daniel E. Ross, Debra Hanna, Laura A. Skerlos, Robert C. Gadwood, Wade J. Adams, Paul J. Pagano, Aristoff Paul A, Christopher Huber, J.V.N. Vara Prasad, Charles W. Ford
Publikováno v:
Journal of Medicinal Chemistry. 50:5886-5889
Oxazolidinones possessing a C-5 carboxamide functionality (reverse amides) represent a new series of compounds that block bacterial protein synthesis. These reverse amides also exhibited less potency against monoamine oxidase (MAO) enzymes and thus p
Autor:
Gregg M. Kamilar, Gary E. Zurenko, J. Craig Ruble, Earline P. Melchior, Keith R. Marotti, Michael T. Sweeney, Brian D. Wakefield, Donna L. Romero
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:4040-4043
The discovery and initial optimization of a novel anthranilic acid derived class of antibacterial agents which suffered from extensive protein binding has been previously reported. The structure-activity relationships around the carboxylic acid subst
Autor:
Gary E. Zurenko, Keith R. Marotti, Atli Thorarensen, Ronald W. Sarver, Michael T. Sweeney, Donna L. Romero, Brian D. Wakefield, Jianke Li
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:3113-3116
In the past few years a significant effort has been devoted by Pharmacia toward the discovery of novel antibiotics. We have recently described the identification of an anthranilic acid lead 1 and the optimization resulting in the advanced lead 2. In
Autor:
Michael T. Sweeney, Donna L. Romero, Garold L. Bryant, Gary E. Zurenko, Fusen Han, Douglas C. Rohrer, Atli Thorarensen, Keith R. Marotti, Brian D. Wakefield
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:2823-2827
In the past few years, a significant effort has been devoted by Pharmacia toward the discovery of novel antibiotics. We have recently described the identification of an anthranilic acid lead 1 and the optimization resulting in the advanced lead 2. In
Autor:
Douglas C. Rohrer, Cory M. Stiff, Jianke Li, Brian D. Wakefield, Keith R. Marotti, Michael T. Sweeney, Donna L. Romero, Gary E. Zurenko, J. Craig Ruble, Atli Thorarensen
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:2347-2350
Discovery of novel antibacterial agents is a significant challenge. We have recently reported on our discovery of novel antibacterial agents in which we have rapidly optimized potency utilizing a parallel chemistry approach. These advanced leads suff
Autor:
Anthony W. Yem, W. Rodney Mathews, Atli Thorarensen, Michael John Bohanon, Michael T. Sweeney, Timothy P. Boyle, Cindy L Wolfe, Charlotte L. Heckaman, Keith R. Marotti, Martin R. Deibel, Alice L. Bodnar, Gary E. Zurenko
Publikováno v:
Bioconjugate Chemistry. 15:333-343
Screening of our compound collection identified PNU-92560, a 2-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carboxamide, as a novel antibacterial agent. Extensive analogue development identified that the 2-position of the thiadiazole could be functionalized
Autor:
Janice M. Friis, Charlotte Wu, Sara E. Morin, Joaquim Trias, Bore Raju, Wade J. Adams, Ford Charles W, Ronda D. Schaadt, Stuart Lam, Joe Palandra, Dinesh V. Patel, Joseph Zhou, Maria Courtney, Mikhail F. Gordeev, Sara Lopez, Gary E. Zurenko, C J Hackbarth, Upinder Singh, Robert C. Gadwood, Zhengyu Yuan, Kathleen Mortell
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:4209-4212
Combinatorial libraries of N-acylated 5-(S)-aminomethyloxazolidinone derivatives of S-oxide and S,S-dioxide tetrahydro-4(2H)-thiopyranyl and thiomorpholine phenyloxazolidinone series have been synthesized on a solid phase and evaluated for antimicrob